DTHIB

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

DTHIB  纯度: 98.34%

DTHIB 是一种直接和选择性的 heat shock factor 1 (HSF1) 抑制剂，DTHIB 与 HSF1 DNA 结合域结合的 Kd 为 160 nM。DTHIB 抑制 HSF1 癌症基因标记 (HSF1 CaSig)，并选择性刺激核 HSF1 的降解。DTHIB 具有有效的抗癌活性，可用于前列腺癌的研究。

DTHIB

DTHIB Chemical Structure

CAS No. : 897326-30-6

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
5 mg ￥900 In-stock
10 mg ￥1500 In-stock
25 mg ￥3100 In-stock
50 mg ￥5000 In-stock
100 mg ￥8000 In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

DTHIB 相关产品

•相关化合物库:

  • Covalent Screening Library Plus
  • Bioactive Compound Library Plus
  • Cell Cycle/DNA Damage Compound Library
  • Metabolism/Protease Compound Library
  • Anti-Cancer Compound Library
  • Anti-Aging Compound Library
  • Covalent Screening Library
  • Cytoskeleton Compound Library
  • Transcription Factor Targeted Library

生物活性

DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1. DTHIB has potently anticancer activities and can be used for prostate cancer research[1].

IC50 & Target

Kd: 160 nM (DTHIB binding to the HSF1 DNA binding domain)[1]
体外研究
(In Vitro)

DTHIB (5 μM; 48 hours) treatment of C4-2 cells induces cell cycle arrest, with accumulation in the G1 phase. DTHIB stimulates C4-2 PCa cell entry into senescence[1].
DTHIB (0.5-5 μM; 48 hours; C4-2 prostate cancer) treatment reduces steady-state protein abundance of the molecular chaperones P23, HSP27, HSP70, and HSP90-all bona fide HSF1 targets in C4-2 cells[1].
DTHIB dose-dependently reduces the clonal expansion of both C4-2 and PC-3 PCa cells with EC50 values of 1.2 μM and 3.0 μM, respectively[1].
In mouse embryonic fibroblasts (MEFs), DTHIB (0.5-10 μM) attenuates the robust acute heat shock induction of the HSP70 and HSP25 molecular chaperones in a dose-dependent manner. DTHIB attenuates the heat shock response by reducing the steady-state transcript abundance of multiple molecular chaperones[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: C4-2 cells
Concentration: 5 μM
Incubation Time: 48 hours
Result: Induced cell cycle arrest.

Western Blot Analysis[1]

Cell Line: C4-2 prostate cancer (PCa) cells
Concentration: 0.5 μM, 1 μM, 2.5 μM, 5 μM
Incubation Time: 48 hours
Result: Dose-dependently inhibited expression of molecular chaperones in C4-2 PCa cells.

体内研究
(In Vivo)

DTHIB (5 mg/kg; intraperitoneal injection; daily; for 3 weeks) treatment potently attenuates tumor progression in a C4-2 xenograft mouse model[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nude mice (6 weeks of age) injected with C4-2 cells[1]
Dosage: 5 mg/kg
Administration: Intraperitoneal injection; daily; for 3 weeks
Result: Showed no visible tumor growth over a 3-week period and a 40% reduction in median tumor volume.

分子量

309.68

Formula

C13H9ClFN3O3
CAS 号

897326-30-6
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
In Vitro: 

DMSO : 100 mg/mL (322.91 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.2291 mL 16.1457 mL 32.2914 mL
5 mM 0.6458 mL 3.2291 mL 6.4583 mL
10 mM 0.3229 mL 1.6146 mL 3.2291 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂： 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.08 mg/mL (6.72 mM); Clear solution; Need ultrasonic

    此方案可获得 2.08 mg/mL (6.72 mM) 的澄清溶液。

    以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献

  • [1]. Bushu Dong, et al. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1. Sci Transl Med. 2020 Dec 16;12(574):eabb5647.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务